Related Experiment Videos
Autoimmune myocarditis: cellular mediators of cardiac dysfunction
Marina Afanasyeva1, Dimitrios Georgakopoulos, Noel R Rose
1Cardiovascular Research Group, Faculty of Medicine, University of Calgary, Canada.
Autoimmunity Reviews
|November 18, 2004
Summary
Immune cells drive cardiac disease progression in experimental autoimmune myocarditis (EAM). Understanding these immune responses offers insights into heart failure and dilated cardiomyopathy (DCM).
Area of Science:
- Immunology
- Cardiology
- Pathology
Background:
- Immune mediators are crucial in cardiac disease pathogenesis.
- Experimental autoimmune myocarditis (EAM) serves as a model for immune-mediated heart conditions.
Purpose of the Study:
- To review immune cell roles in EAM-induced cardiac dysfunction.
- To explore insights into dilated cardiomyopathy (DCM) and heart failure.
Main Methods:
- Review of recent findings on inflammatory infiltrate composition in EAM.
- Analysis of immune cell types and products mediating cardiac dysfunction.
Main Results:
- CD4+ T cells are essential for myocarditis initiation; their cardiac infiltration correlates with systolic dysfunction.
- CD8+ T cells, granulocytes, and mast cells directly impact cardiomyocyte function.
- Failure of regulatory mechanisms leads to cardiomyocyte death, fibrosis, and cardiac dysfunction.
Conclusions:
- EAM pathogenesis highlights the immune system's role in cardiac dysfunction.
- EAM serves as a paradigm for autoimmune organ-specific damage, informing heart failure research.